Is Scale-Up Worth It? Challenges in Economic Analysis of Diagnostic Tests for Tuberculosis

David Dowdy and colleagues discuss the complexities of costing new TB diagnostic tests, including GeneXpert, and argue that flexible analytic tools are needed for decision-makers to adapt large-sample cost-effectiveness data to local conditions.

Detalles Bibliográficos
Autores principales: Dowdy, David W., Cattamanchi, Adithya, Steingart, Karen R., Pai, Madhukar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Essay
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3144197/
https://www.ncbi.nlm.nih.gov/pubmed/21814496
http://dx.doi.org/10.1371/journal.pmed.1001063
_version_ 1782208975205302272
author Dowdy, David W.
Cattamanchi, Adithya
Steingart, Karen R.
Pai, Madhukar
author_facet Dowdy, David W.
Cattamanchi, Adithya
Steingart, Karen R.
Pai, Madhukar
author_sort Dowdy, David W.
collection PubMed
description David Dowdy and colleagues discuss the complexities of costing new TB diagnostic tests, including GeneXpert, and argue that flexible analytic tools are needed for decision-makers to adapt large-sample cost-effectiveness data to local conditions.
format Online
Article
Text
id pubmed-3144197
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-31441972011-08-03 Is Scale-Up Worth It? Challenges in Economic Analysis of Diagnostic Tests for Tuberculosis Dowdy, David W. Cattamanchi, Adithya Steingart, Karen R. Pai, Madhukar PLoS Med Essay David Dowdy and colleagues discuss the complexities of costing new TB diagnostic tests, including GeneXpert, and argue that flexible analytic tools are needed for decision-makers to adapt large-sample cost-effectiveness data to local conditions. Public Library of Science 2011-07-26 /pmc/articles/PMC3144197/ /pubmed/21814496 http://dx.doi.org/10.1371/journal.pmed.1001063 Text en Dowdy et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Essay
Dowdy, David W.
Cattamanchi, Adithya
Steingart, Karen R.
Pai, Madhukar
Is Scale-Up Worth It? Challenges in Economic Analysis of Diagnostic Tests for Tuberculosis
title Is Scale-Up Worth It? Challenges in Economic Analysis of Diagnostic Tests for Tuberculosis
title_full Is Scale-Up Worth It? Challenges in Economic Analysis of Diagnostic Tests for Tuberculosis
title_fullStr Is Scale-Up Worth It? Challenges in Economic Analysis of Diagnostic Tests for Tuberculosis
title_full_unstemmed Is Scale-Up Worth It? Challenges in Economic Analysis of Diagnostic Tests for Tuberculosis
title_short Is Scale-Up Worth It? Challenges in Economic Analysis of Diagnostic Tests for Tuberculosis
title_sort is scale-up worth it? challenges in economic analysis of diagnostic tests for tuberculosis
topic Essay
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3144197/
https://www.ncbi.nlm.nih.gov/pubmed/21814496
http://dx.doi.org/10.1371/journal.pmed.1001063
work_keys_str_mv AT dowdydavidw isscaleupworthitchallengesineconomicanalysisofdiagnostictestsfortuberculosis
AT cattamanchiadithya isscaleupworthitchallengesineconomicanalysisofdiagnostictestsfortuberculosis
AT steingartkarenr isscaleupworthitchallengesineconomicanalysisofdiagnostictestsfortuberculosis
AT paimadhukar isscaleupworthitchallengesineconomicanalysisofdiagnostictestsfortuberculosis

Ejemplares similares